Skip to main navigation
Skip to search
Skip to main content
University of Canberra Research Portal Home
Home
Profiles
Research output
Projects
Press/Media
Activities
Research units
Prizes
Student theses
Search by expertise, name or affiliation
Pathobiology of respiratory syncytial virus (RSV)
Ralph A. Tripp, Paul S. McNamara
Research output
:
Contribution to journal
›
Editorial
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pathobiology of respiratory syncytial virus (RSV)'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pathobiology
100%
Respiratory Syncytial Virus
100%
Haematopoietic Stem Cell Transplant Recipients
60%
Antibody Response
40%
Vaccine Development
40%
Disease Pathogenesis
20%
Amino Acids
20%
Fusion Protein
20%
Lower Respiratory Tract Infection
20%
Respiratory Syncytial Virus Infection
20%
Development Effort
20%
Health Burden
20%
Respiratory Syncytial Virus Vaccines
20%
Immune-compromised
20%
F Protein
20%
Nasal Wash
20%
Immunity Development
20%
Furin
20%
Cleavable
20%
Immunodominant Peptide
20%
Piedra
20%
Furin Cleavage
20%
Pharmacology, Toxicology and Pharmaceutical Science
Human respiratory syncytial virus
100%
Diseases
60%
Vaccine Development
40%
Furin
40%
Amino Acid
20%
Infection
20%
Respiratory Tract
20%
Respiratory Syncytial Virus Infection
20%
Chimeric Protein
20%
Respiratory Syncytial Virus Vaccine
20%
Piedra
20%
Protein P27
20%
Obstruction
20%
Immunology and Microbiology
Human respiratory syncytial virus
100%
Hematopoietic Cell
60%
Antibody Response
40%
Peptides
40%
Lower Respiratory Tract
20%
Respiratory Syncytial Virus Infection
20%
Amino Acid
20%
Respiratory Syncytial Virus Vaccine
20%
Infection
20%